Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Oncolytic Viruses
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(2)
1 / 1
Ovarian Cancer
Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer
David Alvaro, Ph.D.; Jason Litten, M.D.
Pharma's Almanac
PAO-04-26-CL-03
Apr 21, 2026
Virotherapy
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-12-24-CL-1
Dec 2, 2024
1 / 1